Cindy Hyde-Smith said...
I sent you a bicameral letter requesting that you immediately rescind the removal of in-person dispensing requirements for this drug.
Context
Hyde-Smith expressed concern over the FDA's decision on mifepristone dispensing.
04/27/2022